| abstract |
The present invention provides biomarkers for efficient and accurate characterization of mast cell activity-associated diseases, disorders and/or conditions. In particular, the present invention provides biomarkers expressed in mast cell activity-associated diseases, disorders and/or conditions. Those biomarkers, used alone or in combination, may permit more accurate robust characterization of mast cell activity-associated diseases, disorders and/or conditions, resulting in more precise determination of their diagnosis and treatment, and in particular, prediction of the occurrence of MS relapse. |